RBPJ was shown to promote GBM cell proliferation, invasion, stemness, and tumor initiation via enhancing activation of the IL-6-STAT3 pathway and proneural-mesenchymal transition (PMT) [47]. The gene discussed is IL6; the disease is glioblastoma.